Skip to main content

Greedy Insider

AGMB Insider Trades and Greediness Scores

AgomAb Therapeutics NV (AGMB) insider trades: since Oct 5, 2026, Greedy Insider recorded 10 open-market buys and 0 sales on Form 4 from 3 insiders. The strongest recent filing scored 84 (Strong).

Who bought and who sold

Across the last 10 scoreable Form 4 transactions in AGMB, 10 were open-market purchases and 0 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.

InsiderRoleTypeSharesDateScore
Epstein David RDirectorBuy5000.044300.02026-10-2167View
Epstein David RDirectorBuy5000.044500.02026-10-2166View
Epstein David RDirectorBuy5000.044500.02026-10-0874View
Epstein David RDirectorBuy5000.043500.02026-10-0676View
Kemula Pierre Thadee VictorCFOBuy3000.026010.02026-10-0677View
Kemula Pierre Thadee VictorCFOBuy5000.042850.02026-10-0684View
Kemula Pierre Thadee VictorCFOBuy2000.017080.02026-10-0672View
Knotnerus Tim JasperCEOBuy5000.043500.02026-10-0680View
Epstein David RDirectorBuy5000.042850.02026-10-0571View
Knotnerus Tim JasperCEOBuy6000.050880.02026-10-0577View

The strongest recent filing

Kemula Pierre Thadee Victor (CFO) bought 5,000 shares of AgomAb Therapeutics NV on Oct 6, 2026, a filing that scored 84 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.

Cluster activity

A cluster buy is present: 3 insiders (Epstein David R, Kemula Pierre Thadee Victor, Knotnerus Tim Jasper) traded AGMB the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.

How this compares with AgomAb Therapeutics NV's own history

Open-market buys make up 100% of the 10 scoreable AGMB transactions on record between Oct 5, 2026 and Oct 21, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.

Methodology and sources

Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.

Key facts

  • Scoreable Form 4 transactions on record: 10
  • Open-market buys: 10
  • Sales: 0
  • Distinct insiders: 3
  • Strongest recent Greediness Score: 84 (Strong)

Primary sources

Related

The score describes the filing, not future returns. This is not investment advice.